IGI, Laboratories, Inc.
105 Lincoln Avenue
Buena,
NJ 08310
United States - Map
Phone: 856-697-1441
Fax: 856-697-1001
Web Site: http://www.askigi.com
| IGI Laboratories, Inc. engages in the development, manufacture, filling, and packaging of topical, semi solid, and liquid products for pharmaceutical, cosmeceutical, and cosmetic companies. The company focuses on the commercialization of its licensed Novasome encapsulation technology for skin care/treatment products. It licenses the Novasome encapsulation technology from Novavax, Inc. for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological over-the-counter and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals, as well as the processes for making the same. The company was formerly known as IGI, Inc. and changed its name to IGI Laboratories, Inc. in May 2008. IGI Laboratories, Inc. was founded in 1977 and is headquartered in Buena, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. Nadya Lawrence , 40
Exec. VP of Operations |
N/A
| N/A | Mr. Hemanshu N. Pandya , 37
Chief Exec. Officer, Pres |
N/A
| N/A | Ms. Justine Kostka , 55
Principal Financial Officer and Assistant Controller |
N/A
| N/A | Mr. Philip S. Forte ,
Sec. and Corp. Controller |
N/A
| N/A | Mr. Neil Findley ,
Sales and Marketing Director |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
